Previous 10 |
Marketing Alliance ( OTCPK:MAAL ): Q1 GAAP EPS of $0.03. More news on: The Marketing Alliance, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
The Marketing Alliance, Inc. (OTC: MAAL) (“TMA” or the “Company”), today announced financial results for its fiscal 2020 first quarter ended June 30, 2019. FY 2020 First Quarter Financial Highlights (all comparisons to the prior year period) Revenues ...
Marketing Alliance ( OTCPK:MAAL ): Q4 GAAP EPS of $0.12. More news on: The Marketing Alliance, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
The Marketing Alliance, Inc. (OTC: MAAL) (“TMA” or the “Company”), today announced financial results for its fiscal 2019 fourth quarter and year ended March 31, 2019. FY 2019 Fourth Quarter Financial Highlights (all comparisons to the prior year period) ...
The Marketing Alliance, Inc. (OTC: MAAL) (“TMA” or the “Company”), today announced that its Board of Directors has declared a $0.19 per share cash dividend for shareholders of record on May 10, 2019, to be paid on or about May 30, 2019. The Company also paid...
The Marketing Alliance, Inc. (OTC: MAAL) (“TMA” or the “Company”), today announced financial results for its fiscal 2019 third quarter ended December 31, 2018. FY 2019 Third Quarter Financial Highlights (all comparisons to the prior year) Revenues in...
News, Short Squeeze, Breakout and More Instantly...
Marketing Alliance Inc Company Name:
MAAL Stock Symbol:
OTCMKTS Market:
Marketing Alliance Inc Website:
The Marketing Alliance, Inc. (OTC: MAAL) (“TMA” or the “Company”), announced its financial results today for its fiscal 2024 fourth quarter ended March 31, 2024. FY 2024 Financial Key Items (all comparisons to the prior year period) Revenues were $19,58...
The Marketing Alliance, Inc. (OTC: MAAL) (“TMA” or the “Company”), announced its financial results today for its fiscal 2024 third quarter ended December 31, 2023. Third Quarter Fiscal 2024 Financial Key Items (all comparisons to the prior year period) ...
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...